# Hypofractionated Boost vs Conventionally Fractionated Boost for Localized High Risk Prostate Cancer

> **NCT03526510** · NA · UNKNOWN · sponsor: **Dr. Patrick Cheung** · enrollment: 178 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Conventionally Fractionated versus Hypofractionated Boost

## Key facts

- **NCT ID:** NCT03526510
- **Lead sponsor:** Dr. Patrick Cheung
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2021-11
- **Final completion:** 2024-12
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2022-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03526510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03526510, "Hypofractionated Boost vs Conventionally Fractionated Boost for Localized High Risk Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03526510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*